Print this page
-
Evaluating, Preparing, and Responding to Care Disruptions and Health Outcomes Among Patients with Breast Cancer Following Severe Storms
Protocol: 002405Applicable Disease Sites: Breast
-
Evaluating, Preparing, and Responding to Care Disruptions and Health Outcomes Among Patients with Breast Cancer Following Severe Storms
Protocol: 002405Applicable Disease Sites: Breast
-
A Cluster Randomized Trial of a Breast Cancer Treatment Decision Aid for Women 70+ with Low-Risk Stage I Breast Cancers.
Protocol: 002552Principal Investigator:
- Susan Pories
Applicable Disease Sites: Breast -
Wholeness in Healing: Evaluating the Effect of Quality of Life (QOL) on Integrative Therapy Interventions Performed During Outpatient Systemic Therapy Treatment for Women with Stage IIII Breast Cancer- A Pilot Study.
Protocol: 002553Applicable Disease Sites: Breast
-
Uncovering the Tumor Microbiome in Breast Cancer: Toward Spatial
Architecture and Risk Stratification
Protocol: 002634Principal Investigator:
- Tengteng Wang
Applicable Disease Sites: Breast -
A Cluster Randomized Trial of a Breast Cancer Treatment Decision Aid for Women 70+ with Low-Risk Stage I Breast Cancers.
Protocol: 002552Principal Investigator:
- Susan Pories
Applicable Disease Sites: Breast -
Wholeness in Healing: Evaluating the Effect of Quality of Life (QOL) on Integrative Therapy Interventions Performed During Outpatient Systemic Therapy Treatment for Women with Stage IIII Breast Cancer- A Pilot Study.
Protocol: 002553Applicable Disease Sites: Breast
-
Uncovering the Tumor Microbiome in Breast Cancer: Toward Spatial
Architecture and Risk Stratification
Protocol: 002634Principal Investigator:
- Tengteng Wang
Applicable Disease Sites: Breast -
I-SPY 2 TRIAL: (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2).
Protocol: 042102Principal Investigator:
- Coral Omene
Applicable Disease Sites: Breast -
I-SPY 2 TRIAL: (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2).
Protocol: 042102Principal Investigator:
- Coral Omene
Applicable Disease Sites: Breast -
Video Education with Result Dependent dIsclosure (VERDI)
Protocol: 042207Principal Investigator:
- Deborah L Toppmeyer
Applicable Disease Sites: Breast
Colon
Kidney
Melanoma, Skin
Ovary
Pancreas
Prostate
Soft Tissue -
Video Education with Result Dependent dIsclosure (VERDI)
Protocol: 042207Principal Investigator:
- Deborah L Toppmeyer
Applicable Disease Sites: Breast
Colon
Kidney
Melanoma, Skin
Ovary
Pancreas
Prostate
Soft Tissue -
A Phase II Study of Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer.
Protocol: 042208Principal Investigator:
- Coral Omene
Applicable Disease Sites: Breast -
A Phase II Study of Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer.
Protocol: 042208Principal Investigator:
- Coral Omene
Applicable Disease Sites: Breast -
Pilot Study to Investigate the Metabolic Pathways in Hormone Receptor-Positive/HER2-Negative Breast Cancer.
Protocol: 042210Principal Investigator:
- Coral Omene
Applicable Disease Sites: Breast -
Pilot Study to Investigate the Metabolic Pathways in Hormone Receptor-Positive/HER2-Negative Breast Cancer.
Protocol: 042210Principal Investigator:
- Coral Omene
Applicable Disease Sites: Breast